<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> is caused by disruption of the ubiquitin-protein ligase E3A gene (UBE3A) </plain></SENT>
<SENT sid="1" pm="."><plain>The gene encodes an ubiquitinating protein that is widely expressed in the body but has tissue-specific expression in brain neurons, resulting in transcription from only the maternal allele </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_458'>normal</z:mpath> function of this protein is beginning to be delineated, but its protein targets and role in various cellular pathways remain elusive </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> mouse models lacking the protein in the brain provide insight into neuronal cell dysfunction, particularly in hippocampal neurons where dendritic structure and synaptic function become disturbed </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman Syndrome</z:e> Foundation's 2009 symposium theme was thus ''<z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman Syndrome</z:e> at the Synapse,'' and the event enabled neuroscientists and other researchers and clinicians to present their current research on the syndrome </plain></SENT>
</text></document>